Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 90. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The cytokine storm and COVID‐19955
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation922
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)710
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines571
The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis485
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis430
Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis411
Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes405
Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis401
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein393
False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence377
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs337
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant327
Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis327
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students292
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis288
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China286
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis278
Role of Toll‐like receptors in the pathogenesis of COVID‐19251
A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)236
Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19219
Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review219
Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity217
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective211
Obesity aggravates COVID‐19: A systematic review and meta‐analysis204
OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear198
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review191
Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients186
A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sex181
Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa173
The value of clinical parameters in predicting the severity of COVID‐19172
Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review172
Psychological stress of medical staffs during outbreak of COVID‐19 and adjustment strategy171
Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?170
Tocilizumab for the treatment of severe coronavirus disease 2019169
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers160
Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis159
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark159
A brief review of influenza virus infection158
Emerging coronaviruses: Genome structure, replication, and pathogenesis153
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples149
Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!149
SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways147
Prolonged SARS‐CoV‐2 RNA shedding: Not a rare phenomenon142
Omicron variant genome evolution and phylogenetics141
Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: A systematic review and meta‐analysis140
Encephalopathy in patients with COVID‐19: A review140
Clinical characteristics and outcomes of cancer patients with COVID‐19140
Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?139
Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test137
Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID‐19: Meta‐analysis and sensitivity analysis135
A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic131
The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak129
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients127
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients126
Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis122
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K122
Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross‐sectional study121
Emergence of Omicron third lineage BA.3 and its importance120
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experience119
Analysis of 92 deceased patients with COVID‐19119
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19119
Extrapulmonary complications of COVID‐19: A multisystem disease?117
The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infe116
Long COVID syndrome‐associated brain fog114
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment113
Conjunctivitis and COVID‐19: A meta‐analysis113
Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy111
Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread110
Influenza and COVID‐19 coinfection: Report of six cases and review of the literature109
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy108
Long COVID and chronic COVID syndromes107
Multisystem inflammatory syndrome in children related to COVID‐19: A New York City experience106
Safety of COVID‐19 vaccines104
Obesity aggravates COVID‐19: An updated systematic review and meta‐analysis103
Droplet digital PCR of viral ‎DNA/RNA, current progress, challenges, and future perspectives102
Expression of the COVID‐19 receptor ACE2 in the human conjunctiva100
Clinical performance of different SARS‐CoV‐2 IgG antibody tests99
The “post‐COVID” syndrome: How deep is the damage?98
Asymptomatic SARS‐CoV‐2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days98
Autoimmune complications of COVID‐1997
Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms96
Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)95
Anemia is associated with severe illness in COVID‐19: A retrospective cohort study94
Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic94
Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients94
Evolutionary dynamics of SARS‐CoV‐2 nucleocapsid protein and its consequences93
Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection93
Bacterial infections and patterns of antibiotic use in patients with COVID‐1992
Targeting human TLRs to combat COVID‐19: A solution?91
0.035440921783447